AnGes Inc
OTC:AMGXF
AnGes Inc
OTC:AMGXF
Price:
0.3602
USD
Market Closed
Market Cap:
$78.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
AnGes Inc
OTC:AMGXF
|
JP |
|
Man Wah Holdings Ltd
HKEX:1999
|
HK |
|
Paid Inc
OTC:PAYD
|
US |
|
R
|
Royal Unibrew A/S
CSE:RBREW
|
DK |
|
T
|
Telsys Ltd
TASE:TLSY
|
IL |
|
S
|
Susco PCL
SET:SUSCO
|
TH |
|
I
|
Inbest Prime VI Inmuebles Socimi SA
MAD:YINB6
|
ES |
|
T
|
TMC Life Sciences Bhd
KLSE:TMCLIFE
|
MY |
|
Gungnir Resources Inc
XTSX:GUG
|
CA |
|
S
|
Sunview Group Bhd
KLSE:SUNVIEW
|
MY |
|
SBC Medical Group Holdings Inc
NASDAQ:SBC
|
US |
Multiples-Based Value
The Multiples-Based Value of one
AMGXF
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.3602 USD,
AnGes Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AMGXF Multiples-Based Value
LOCKED
Multiples Across Competitors
AMGXF Competitors Multiples
AnGes Inc Competitors
AnGes Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
AnGes Inc
OTC:AMGXF
|
22.6B USD | 25.8 | -4.3 | -4.1 | -4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
367.6B USD | 6 | 87.8 | 14.6 | 20.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.5B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD | 9.2 | 28 | 21 | 22 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
42.2B EUR | 11.9 | 38.2 | 41.3 | 42.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.1B AUD | 3 | 32.9 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
